Monitoring the Session

HB 2528

Bucy Opioid Bill Bans Prior Authorization “Except As Needed”

Died in committee

Verdict: Smells

SmellsInitial review
Rep. John H. Bucy IIIDHouse 136
Why it's charged
The hole

THE TEXT

…“except as needed to minimize the opportunity for fraud, waste, and abuse”

Bill text, introduced version (I)

The ban on prior authorization carries an undefined exception for fraud, waste and abuse. A plan could cite that reason for almost any prior-authorization requirement, which would weaken the ban in its main case.

The hole

Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade

Caption

relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

Caption from analyzed text · version I.

Summary

The exception is undefined. A plan could cite it for almost any prior authorization.

The bill bars Texas health insurance plans that cover medication-assisted treatment for opioid or substance use disorder from requiring patients to get prior approval before receiving it. It covers methadone, buprenorphine, buprenorphine/naloxone and naltrexone across most state-regulated private plans, but not Medicaid or the children's health plan. Plans issued or renewed on or after January 1, 2026 lose the prior-approval step for these drugs, except where the plan says prior approval is needed to fight fraud, waste and abuse.

Labels

Labels: ZOMBIE BILL. Died 2 times: 88R HB 5230 (Did not pass) and this bill (Died in committee). Checked against 88R only.DO-OVER. Reworked text of a bill filed before that died: 88R HB 5230 (Did not pass). Filed in 2 sessions, counting this one. Checked against 88R only.TRY NO. 2. Filed in 2 sessions: 88R and 89R. Checked against 88R only.PENDING FOREVER. Heard by the House Insurance committee on Apr 9, 2025 and left pending. Never voted out. The bill died.

Receipt

The receipt

89R-HB2528 · 2025-02-06

SOLD BY

ITEM

relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

WHAT IT DOES

The exception is undefined. A plan could cite it for almost any prior authorization.

The bill bars Texas health insurance plans that cover medication-assisted treatment for opioid or substance use disorder from requiring patients to get prior approval before receiving it. It covers methadone, buprenorphine, buprenorphine/naloxone and naltrexone across most state-regulated private plans, but not Medicaid or the children's health plan. Plans issued or renewed on or after January 1, 2026 lose the prior-approval step for these drugs, except where the plan says prior approval is needed to fight fraud, waste and abuse.

CHARGES

[x] THE HOLEanalysis confidence 50%

THE TEXT

…“except as needed to minimize the opportunity for fraud, waste, and abuse”

Bill text, introduced version (I)

The ban on prior authorization carries an undefined exception for fraud, waste and abuse. A plan could cite that reason for almost any prior-authorization requirement, which would weaken the ban in its main case.

TOTAL

No significant fiscal implication to the State is anticipated.

LBB estimate · fiscal note version I · source

Sources

Fiscal note · version I · April 8, 2025

No first-year general revenue figure available here.

LBB published estimates · flow over the stated periods.

Source snapshot 2026-10-19, Central time.

HISTORY

  1. Filed
  2. Read first time
  3. Referred to Insurance
  4. Scheduled for public hearing on . . .
  5. Considered in public hearing
  6. Testimony taken/registration(s) recorded in committee
  7. Left pending in committee
FILED UNDER

No verified beat found.

Smells

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Not tied to this bill.

Sources

The author's campaign account only. Own money and internal transfers are separate on the member page.

Derived itemized flow · Oct 28, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Agave Democratic Infrastructure Fund$56,000.00

Agave Democratic Infrastructure Fund

$56,000.00

Cash
$25,000.00
Paid by others
$31,000.00
Total
$56,000.00
consulting $31,000.00

Also funds 5 other sitting lawmakers.

Derived recipient stock · Nov 22, 2024 to Oct 12, 2026. State data as of Nov 4, 2026.

TEC account match.

Sources

Derived itemized flow · Nov 22, 2024 to Oct 12, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100986907, 101059773, 101069326, 101072293.

Adam Loewy$20,000.00
Texas Sands PAC$17,000.00

Texas Sands PAC

$17,000.00

Cash
$17,000.00
Paid by others
$0.00
Total
$17,000.00

Also funds 121 other sitting lawmakers.

Derived recipient stock · Jul 3, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 9, 2024 to Sep 29, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100986907, 101032801, 101059773, 101072293.

Money

Missing data does not establish zero giving. Display amounts are rounded.

×

Agave Democratic Infrastructure Fund

$56,000.00

Cash
$25,000.00
Paid by others
$31,000.00
Total
$56,000.00
consulting $31,000.00

Also funds 5 other sitting lawmakers.

Derived recipient stock · Nov 22, 2024 to Oct 12, 2026. State data as of Nov 4, 2026.

TEC account match.

Sources

Derived itemized flow · Nov 22, 2024 to Oct 12, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100986907, 101059773, 101069326, 101072293.

×

Texas Sands PAC

$17,000.00

Cash
$17,000.00
Paid by others
$0.00
Total
$17,000.00

Also funds 121 other sitting lawmakers.

Derived recipient stock · Jul 3, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 9, 2024 to Sep 29, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100986907, 101032801, 101059773, 101072293.

Votes

No floor vote loaded for this bill.

Fiscal

No significant fiscal implication to the State is anticipated.

LBB estimate · fiscal note version I · source

Sources

Fiscal note · version I · April 8, 2025

No first-year general revenue figure available here.

LBB published estimates · flow over the stated periods.

Source snapshot 2026-10-19, Central time.

How this was graded

Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.

FILED BEFORE

Filed 2 times: 88R and 89R. Checked against 88R only.

88R HB 5230

by Rep. Bucy, same lead author · Did not pass · reworked

Introduced text

Last action, Apr 18, 2023: Withdrawn from schedule

Relating to health benefit plan coverage of prescription drugs for serious mental illnesses and opioid and substance use disorders.

Caption, 88R bill history

Sources

Texas House · Filed Feb 6, 2025

04/09/2025 H Left pending in committee

Texas Legislature Online · Introduced

Data snapshot Oct 26, 2026 at 4:19 AM CDT. Grades, charges, quotes and corrections follow the published record.

House committee · Insurance · Final status: Died in committee

Subjects

Insurance--Health & Accident

Mental Health & Substance Abuse

MEDICINE & PRESCRIPTION DRUGS

Text

The text as introduced · 596 words

By: Bucy
H.B. No. 2528

A BILL TO BE ENTITLED

AN ACT

relating to health benefit plan coverage of prescription drugs for

opioid and substance use disorders.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Chapter 1369, Insurance Code, is amended by

adding Subchapter E-3 to read as follows:

SUBCHAPTER E-3. COVERAGE OF MEDICATION-ASSISTED TREATMENT

FOR OPIOID OR SUBSTANCE USE DISORDER

Sec. 1369.231. DEFINITION. In this subchapter,

"medication-assisted opioid or substance use disorder treatment"

means the use of methadone, buprenorphine, buprenorphine/naloxone,

or naltrexone to treat opioid or substance use disorder.

Sec. 1369.232. APPLICABILITY OF SUBCHAPTER. (a) This

subchapter applies only to a health benefit plan that provides

benefits for medical or surgical expenses incurred as a result of a

health condition, accident, or sickness, including an individual,

group, blanket, or franchise insurance policy or insurance

agreement, a group hospital service contract, or an individual or

group evidence of coverage or similar coverage document that is

issued by:

(1) an insurance company;

(2) a group hospital service corporation operating

under Chapter 842;

(3) a health maintenance organization operating under

Chapter 843;

(4) an approved nonprofit health corporation that

holds a certificate of authority under Chapter 844;

(5) a multiple employer welfare arrangement that holds

a certificate of authority under Chapter 846;

(6) a stipulated premium company operating under

Chapter 884;

(7) a fraternal benefit society operating under

Chapter 885;

(8) a Lloyd's plan operating under Chapter 941; or

(9) an exchange operating under Chapter 942.

(b) Notwithstanding any other law, this subchapter applies

to:

(1) a small employer health benefit plan subject to

Chapter 1501, including coverage provided through a health group

cooperative under Subchapter B of that chapter;

(2) a standard health benefit plan issued under

Chapter 1507;

(3) nonprofit agricultural organization health

benefits offered by a nonprofit agricultural organization under

Chapter 1682;

(4) alternative health benefit coverage offered by a

subsidiary of the Texas Mutual Insurance Company under Subchapter

M, Chapter 2054;

(5) health benefits provided by or through a church

benefits board under Subchapter I, Chapter 22, Business

Organizations Code;

(6) a regional or local health care program operated

under Section 75.104, Health and Safety Code; or

(7) a self-funded health benefit plan sponsored by a

professional employer organization under Chapter 91, Labor Code.

(c) This subchapter applies to coverage under a group health

benefit plan provided to a resident of this state regardless of

whether the group policy, agreement, or contract is delivered,

issued for delivery, or renewed in this state.

Sec. 1369.233. EXCEPTIONS TO APPLICABILITY OF SUBCHAPTER.

This subchapter does not apply to an issuer or provider of health

benefits under or a pharmacy benefit manager administering pharmacy

benefits under:

(1) the state Medicaid program, including the Medicaid

managed care program under Chapter 533, Government Code; or

(2) the child health plan program under Chapter 62,

Health and Safety Code.

Sec. 1369.234. LIMITATIONS ON PRIOR AUTHORIZATION. A

health benefit plan that provides coverage for medication-assisted

opioid or substance use disorder treatment may not require an

enrollee to obtain prior authorization for the treatment, except as

needed to minimize the opportunity for fraud, waste, and abuse.

SECTION 2. This Act applies only to a health benefit plan

delivered, issued for delivery, or renewed on or after January 1,

2026. A health benefit plan delivered, issued for delivery, or

renewed before January 1, 2026, is governed by the law as it existed

immediately before the effective date of this Act, and that law is

continued in effect for that purpose.

SECTION 3. This Act takes effect September 1, 2025.